Become a member
Menu Back to DIA-2013-49th-Annual-Meeting-Advancing-Therapeutic-Innovation-and-Regulatory-Science

Program Committee

  • Sandra A. Milligan, DIAFellow, JD, MD
    Sandra A. Milligan, DIAFellow, JD, MD • Senior Vice President, Head of Global Regulatory Affairs and Clinical Safety
    Merck Research Laboratories, United States
  • J. Lynn Bass, PharmD
    J. Lynn Bass, PharmD • Director, Medical Science Liaisons, Americas
    Santen, Inc., United States
  • Annetta C. Beauregard, MBA, MS
    Annetta C. Beauregard, MBA, MS • Vice President, US Regulatory Strategy
    EMD Serono, Inc., United States
  • Larry A. Blankstein, PhD
    Larry A. Blankstein, PhD • Head of Clinical Operations
    Synlogic, United States
  • Linda Bowen, MSc, RAC
    Linda Bowen, MSc, RAC • Assistant Professor
    Temple University, United States
  • Joan Buenconsejo, PhD, MPH
    Joan Buenconsejo, PhD, MPH • Director and Biometrics Team Leader
    AstraZeneca, United States
  • Jonca C. Bull, MD
    Jonca C. Bull, MD • Vice President, Regulatory Consulting
    PPD, United States
  • Thomas M. Casola, MBA
    Thomas M. Casola, MBA • Head, Global Regulatory Affairs, Advertising and Promotion
    Shire Specialty Pharmaceuticals, United States
  • Nancie E. Celini, DrPH
    Nancie E. Celini, DrPH • Chief Health Technology Advisor and Educator
    CAB Inc., United States
  • Leah Christl, PhD
    Leah Christl, PhD • Associate Director for Therapeutic Biologics, TBBS, OND, CDER
    FDA, United States
  • Anne B. Cropp, PharmD
    Anne B. Cropp, PharmD • Vice President
    Pfizer Inc, United States
  • Nancy A. Dreyer, DIAFellow, PhD, MPH, FISPE
    Nancy A. Dreyer, DIAFellow, PhD, MPH, FISPE • Global Chief, Sci Affairs; Sr VP, Head, Center for Advanced Evidence Generation
    IQVIA, United States
  • Charles Drucker, MBA
    Charles Drucker, MBA • Director of Operations and Project Management
    Quest Diagnostics, United States
  • Lauren Edelstein Henry
    Lauren Edelstein Henry • Senior Principal Operational Specialist
    Janssen Pharmaceutical Companies of Johnson & Johnson, United States
  • Kathleen Findlen
    Kathleen Findlen • Head of Clinical Operations and Project Management
    Piramal Life Sciences, United States
  • Ron D. Fitzmartin, DIAFellow, PhD, MBA
    Ron D. Fitzmartin, DIAFellow, PhD, MBA • Senior Advisor, Office of Strategic Programs, CDER
    FDA, United States
  • Michael Folkendt, MS
    Michael Folkendt, MS • Associate Director For Regulatory Affairs
    FDA, United States
  • Stacey M. Fung, PharmD
    Stacey M. Fung, PharmD • Associate Director, Medical Communications
    Genentech, A Member of the Roche Group, United States
  • Jonathan Haddad, MPH
    Jonathan Haddad, MPH • Director, Clinical Statistics
    GlaxoSmithKline, United States
  • Martin Harvey Allchurch, LLM
    Martin Harvey Allchurch, LLM • Principal International Affairs Officer
    European Medicines Agency, European Union, United Kingdom
  • Alan M. Hochberg
    Alan M. Hochberg • Scientific Enablement Leader
    F. Hoffmann-La Roche Ltd., Switzerland
  • Mark J. Hope
    Mark J. Hope • Vice President, Global Head of Regulatory Affairs
    UCB SA, Switzerland
  • Chris Hoyle, MBA
    Chris Hoyle, MBA • Executive Director
    Elite Research Network, United States
  • David Jacobson-Kram, PhD
    David Jacobson-Kram, PhD • Associate Director for Pharmacology and Toxicology, Office of New Drugs, CDER
    FDA, United States
  • Nirdosh Jagota, PhD
    Nirdosh Jagota, PhD • Vice President and Head, Regulatory CMC
    Merck & Co., Inc., United States
  • Janet Jenkins-Showalter
    Janet Jenkins-Showalter • Head, US Regulatory Policy
    Genentech, A Member of the Roche Group, United States
  • Agnes V. Klein, MD
    Agnes V. Klein, MD • Director, Evaluation of Radiopharmaceuticals and Biotherapeutic Products
    Health Canada, Canada
  • Tatsuo Kurokawa, PhD
    Tatsuo Kurokawa, PhD • President
    Japan Self-Medication Industry, Japan
  • Sheila Lapping
    Sheila Lapping • Senior Director, Outsourcing Management
    Takeda Global Research & Development Center Inc., United States
  • Jeffrey Litwin, MD, FACC
    Jeffrey Litwin, MD, FACC • CEO MedAvante / ProPhase
    WIRB-Copernicus Group, United States
  • Barry Mangum, PharmD
    Barry Mangum, PharmD • Chief Executive Officer
    Paidion Research, Inc., United States
  • JeanMarie Markham
    JeanMarie Markham • Chief Executive Officer
    Clinlogix, United States
  • Christopher M. Marrone, PharmD
    Christopher M. Marrone, PharmD • Real World Outcomes Liaison
    Eli Lilly and Company, United States
  • Munish Mehra, PhD
    Munish Mehra, PhD • Executive Director
    Tigermed Co., Ltd., United States
  • Jon Meyer, MBA, MSc
    Jon Meyer, MBA, MSc • Co-Founder and Managing Member
    Life Science Strategy Group, LLC, United States
  • C. Latham Mitchell, MD
    C. Latham Mitchell, MD • Managing Principal
    Erudita Biotechnical LLC, United States
  • Christine M. V. Moore, PhD
    Christine M. V. Moore, PhD • Global Head and Executive Director, GRACS CMC - Policy
    Merck Research Laboratories, United States
  • Patrick C. O'Brien, JD, PharmD
    Patrick C. O'Brien, JD, PharmD • General Counsel
    Arrowhead Research Corporation, United States
  • Shaghig Palanjian, MBA
    Shaghig Palanjian, MBA • Vice President, Global Head, R&D QA and Compliance
    United States
  • James L. Parmentier, PhD
    James L. Parmentier, PhD • Professor
    Retired, United States
  • Pradip Paul, MD, MS
    Pradip Paul, MD, MS • Consultant
    Strategic Pharmacovigilance and Risk Management, United States
  • Kirsten H. Paulson, MS, RAC
    Kirsten H. Paulson, MS, RAC • Senior Director, Global CMC Medical Devices
    Pfizer Inc, United States
  • Kim Quaintance-Lunn
    Kim Quaintance-Lunn • Vice President, Regulatory Policy, NA
    Bayer, United States
  • Badri Rengarajan, MD
    Badri Rengarajan, MD • Medical Affairs Lead, ASPIRE Unit
    Actelion, United States
  • Margaret Richards, PhD, MPH
    Margaret Richards, PhD, MPH • Executive Director, Scientific Affairs, Real-World Solutions
    PRA Health Sciences, United States
  • Lucy Rose, MBA
    Lucy Rose, MBA • President
    Lucy Rose and Associates, LLC, United States
  • Abdul J. Sankoh, PhD, MA, MS
    Abdul J. Sankoh, PhD, MA, MS • Vice President, Data Science
    Sage Therapeutics, Inc. , United States
  • Gregg Schneider
    Gregg Schneider • Director, R&D Financial Management
    Otsuka Pharmaceutical Development & Commercialization, Inc., United States
  • Suzanne Sensabaugh, MBA, MS
    Suzanne Sensabaugh, MBA, MS • President and Principal Consultant
    HartmannWillner LLC, United States
  • Leigh Shultz, PhD
    Leigh Shultz, PhD • Associate Vice President, Project Management
    Merck & Co., Inc., United States
  • Ling Su, DIAFellow, PhD
    Ling Su, DIAFellow, PhD • Past President, DIA Board of Directors; Professor
    Shenyang Pharmaceutical University, China
  • Patrick J. Thomas, MS
    Patrick J. Thomas, MS • Director, US Group Lead - Adult & Travellers Vaccines
    GlaxoSmithKline, United States
  • Carolynn Thomas-Jones
    Carolynn Thomas-Jones •
    The Ohio State University, United States
  • Toshiyoshi Tominaga, PhD
    Toshiyoshi Tominaga, PhD • Associate Executive Director (for International Programs)
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Jurgen Venitz, MD, PhD
    Jurgen Venitz, MD, PhD • Professor, Dept of Pharmaceutics, Pharmacotherapy & Outcomes Sci, Dir PK/PD Lab
    Virginia Commonwealth University, United States
  • Keith W. Wenzel
    Keith W. Wenzel • Senior Director, Solution Incubator
    PAREXEL, United States
  • Albert I. Wertheimer, PharmD, PhD, MBA
    Albert I. Wertheimer, PharmD, PhD, MBA • Professor of Pharmacy Administration, School of Pharmacy
    Temple University, United States
  • Linda Fossati Wood, MPH, RN
    Linda Fossati Wood, MPH, RN • President
    MedWrite, Inc., United States
Load More